Healthcare News

Product Candidates SZN-1326 and SZN-043 Advance Toward Initiation of Clinical Studies in 2022 Expanding and Advancing Discovery Stage Pipeline in Multiple Disease Settings SOUTH SAN FRANCISCO,...

- Third quarter net sales of $16.0 Million, up 6% sequential quarter-over-quarter and 5% year-over-year -       - Company recently submitted Investigational New Drug application with FDA for its...

Den ordinære generalforsamling i Ambu A/S afholdes  tirsdag d. 14. december 2021 kl. 13:00 på adressen Tivoli Hotel & Congress Center, Arni Magnussons Gade 2-4, 1577 København V. ...

Notice is hereby given of the Annual General Meeting of Ambu A/S, which is held on  Tuesday, 14 December 2021 at 1:00 pm (CET) at the premises of Tivoli Hotel & Congress Center, Arni...

Saint-Herblain (France), le 15 novembre 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, annonce aujourd’hui qu’elle présentera son candidat vaccin contre...

Saint-Herblain (France), November 15, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced it will present its Chikungunya vaccine candidate, VLA1553, on...

HASBROUCK HEIGHTS, N.J., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to report today that it will be presenting at the Torrey Hills...

Mechelen, België; 15 november 2021; 16.45 CET; Galapagos NV (Euronext & Nasdaq: GLPG) maakt vandaag bekend dat de Europese Commissie Jyseleca® (filgotinib 200mg tabletten) heeft goedgekeurd voor...

Mechelen, Belgium; 15 November 2021; 16.45 CET; Galapagos NV (Euronext & Nasdaq: GLPG) announced today that the European Commission has granted marketing authorization for Jyseleca® (filgotinib...

Arlington, VA, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Apprenticeship combines education with up to 6,000 hours of on-the-job learning A U.S. national BMET (biomedical equipment technician)...